US-based contract research organisation (CRO) Parexel International has consolidated what it says is already a leading presence in the Latin American clinical research space by opening an office in Lima, Peru.
With the addition of the Lima office, which will provide regulatory consulting and clinical research services, Parexel now has locations in five important biopharmaceutical centres across Latin America, the CRO pointed out – Peru, Argentina, Brazil, Chile and Mexico. The company has around 400 employees in total working in the Latin American region.
Parexel first entered the Latin American market in 1997. “Due to the increasing globalisation of clinical research, client demand for our capabilities in Latin America has been steadily increasing, and over the last seven years Parexel has experienced double-digit growth in the region,” said chairman and chief executive officer Josef von Rickenbach.
“Our experts in Latin America manage complex trials on a regional and worldwide scale,” he added. “Included among the broad array of services we provide, we are helping clients to navigate regulatory environments, identify qualified investigators and access diverse patient populations throughout the region.”
Among the capabilities offered by Parexel’s Latin American offices are regulatory advice for clinical development, as well as project management, site management, data management, medical affairs, biostatistics, and bioanalysis for Phase II-IV studies. The CRO’s clinical logistics team in Latin America helps clients to manage their global clinical trial supply requirements.
Also available are “extensive” late-phase development resources including observational studies, patient registries, outcomes research and expanded access programmes, Parexel noted.
